Skip to content

Pragmatic study of Homoeopathy as adjuvant therapy given along with standard medical management in Persons with Hemophilia and other bleeding disorders

Homoeopathy as adjuvant therapy given along with standard medical management in Persons with Hemophilia and other bleeding disorders-A pragmatic cohort study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024357
Enrollment
100
Registered
2020-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D682- Hereditary deficiency of other clotting factors Health Condition 2: D67- Hereditary factor IX deficiency Health Condition 3: D66- Hereditary factor VIII deficiency Health Condition 4: D68- Other coagulation defects

Interventions

Intervention1: Standard conventional (allopathic/modern)medicine and Homoeopathic Medicines: Known pharmacopoeial preparations of conventional (allopathic/modern)medicine. Known pharmacopoeial prepara

Sponsors

CCRH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. PWH and diagnosed cases of other bleeding disorders of any age group beyond 04 years under standard medical management 2. PWH and other bleeding disorders willing to take adjuvant homoeopathic treatment for Haemophilia 3. Patients willing to sign written informed consent 4. Persons diagnosed with combinations of multi factor deficiencies

Exclusion criteria

Exclusion criteria: 1. PWH or other bleeding disorders with a history of life-threatening bleeds 2. Patients not willing to sign written informed consent

Design outcomes

Primary

MeasureTime frame
-Annualized bleeding rate for all bleeds (ABRall) at the end of 01 year -Annualized bleeding rate for joint bleeds (ABRjoints) at the end of 01 year Timepoint: -Annualized bleeding rate for all bleeds (ABRall) at the end of 01 year -Annualized bleeding rate for joint bleeds (ABRjoints) at the end of 01 year

Secondary

MeasureTime frame
â?¢Haemophilia Joint health score (HJHS) â?¢Pediatric Haemophilia Activities List (PaedHAL)and Haemophilia Activities List (HAL) â?¢Haemo QoL â?¢Requirement of blood transfusion during study â?¢Inhibitor titreTimepoint: Baseline, 6th and 12th month Baseline, 6th and 12th month Baseline and 12th month Baseline, 6th and 12th month Baseline and 12th

Countries

India

Contacts

Public ContactProf Dr Tapas Kundu

Central Council for Research in Homoeopathy

anil23101961@gmail.com9911127619

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026